A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
ModernaTX, Inc.
ModernaTX, Inc.
Akamis Bio
Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc.
Viralytics
Genelux Corporation
Akamis Bio
CG Oncology, Inc.
Novartis
Gilead Sciences
GlaxoSmithKline
AlloVir
GlaxoSmithKline
GlaxoSmithKline
Vaxart
Biotest Pharmaceuticals Corporation
Chiltern Pesquisa Clinica Ltda